Purpose: autoimmunity has been proposed as one of the pathogenesis of abdominal aortic aneurysm (AAA). There is also a likelihood that when aorto-iliac occlusive disease (AIOD) coexists with AAA, some other occlusive atherosclerotic diseases, such as ischemic heart disease and cerebrovascular disease, may develop, leading to a very poor long-term prognosis. Previous studies using serological HLA typing showed that HLA-DR15 was a risk factor for AAA. In this study, we performed HLA-DNA typing by PCR to clarify the relationship between AAA and HLA genotypes in Japanese patients with AAA. In addition, we analyzed whether HLA genotypes are involved in the pathogenesis of AIOD. Results: we examined 78 HLA genotypes of class I (HLA-A and -B) and class II (HLA-DR) and found that 60.4 and 30.4% of 49 AAA patients had HLA-A2 and HLA-B61, respectively. These frequencies were significantly higher than those in control individuals (HLA-A2, p 5 0.05; HLA-B61, p 5 0.005). We also found that 55.6% of nine AAA patients with AIOD had both HLA-B52 and HLA-DR B1 Ã 1502. In contrast, only 10.0% each of 40 AAA patients without AIOD showed HLA-B53 or HLA-DR B1 Ã 1502. Conclusions: this study showed that HLA A-2 and HLA B-61, but not HLA DR-15, were important genetic risk factors for the development of AAA among the Japanese population. We also found high frequencies of HLA-B52 and HLA-DR B1 Ã 1502 in the AAA patients with AIOD than in those without, although this must be confirmed using a larger number of AAA patients with AIOD.
Introduction
It has been suggested that abdominal aortic aneurysm (AAA) is a multifactorial genetic disease autoimmune (AI) characteristics. 1±3 The human HLA region is extremely polymorphic, 4 certain of which may predispose to particular AI diseases. 5 Class-I (HLA-A, and -B) are recognized by receptors on CD8-positive suppressor T cells, while class-II molecules (HLA-DR) are recognized by receptors on CD4-positive helper T cells when attacking and eliminating foreign substances. Through this mechanism, HLA molecules are involved in not only the recognition of self-non-self but also self-defense and pathogenesis of diseases. Previous studies have suggested that HLA-DR15 was associated with AAA. 6±9 Here, we extend these findings by examining the relationship between HLA type and AAA in Japanese patients with and without coexisting aorto-iliac occlusive disease (AIOD). 10 
Patients and Methods
Forty-nine patients (41 men, eight women, mean age (range) 69.3 AE 7.7 (range 47±83) years) with infra-renal AAA were randomly selected from 426 patients undergoing surgical repair between 1974 and 2000. AIOD was based on angiographic findings (475% stenosis, 450% stenosis 45 cm below the common iliac artery, or an ankle pressure index of less than 0.6). Peripheral blood was withdrawn from the patients after obtaining informed consent, and highmolecular-weight DNA was extracted. 11 The control group comprised 237 healthy Japanese volunteers (168 men, 67 women, of mean age of 45 years). 12 HLA-A, -B, -DR and -DRb1 sequences were amplified by PCR using primers specific to each gene and analyzed by agarose gel electrophoresis. Statistical analysis of the number and percentage of subjects expressing specific genes was performed using the chi-squared test. A probability value of p-corrected (p 5 0.05) was considered significant.
Results
HLA class I HLA-A2 was found in 29 AAA patients (60.4%) and 101 controls (42.6%) ( p 0.0358). HLA-B61 was found in 14 AAA patients (30.4%) and 27 controls (11.4%) ( p 0.0018). There were no significant difference between AAA patients and controls with regard to any other class I HLA genes or class-II HLA genes (Tables A-1±A-4) . Five AAA patients with coexisting AIOD (AIOD-positive group) had both HLA B52 and HLA-DR B1 Ã 1502 genotypes. On the other hand, four each of 40 AAA patients without AIOD (AIOD-negative group) had HLA-B52 or HLA-DR B1 Ã 1502. The frequency of HLA-B52 in AIOD-positive group was higher than that in AIOD-negative group ( p 0.032), and that of HLA-DR B1 Ã 1502 in positive group was significantly higher than that in negative group ( p 0.007) ( Table B) . 
Discussion
HLA genetic polymorphisms are race dependent. In a Japanese population, we were unable to confirm the relationship between AAA and HLA-DR15 previously reported African-Americans, 6 or results of Hirose in Japanese AAA patients. 6±9 This may be due to small numbers of patients, differences in methodology (PCR here and lymphocytotoxicity assay previously), or different risk factors. Nine of the AAA patients in the present study also had AIOD. Five of these patients had HLA-DR B1 Ã 1502 genotype, as compared to four of 40 AAA patients without AIOD. Interestingly, all the five patients with HLA-DR B1 Ã 1502 in AIODpositive group had HLA-B52. The significance of this observation is not clear at present and further studies are needed to clarify this point. When considering the possible relationship between HLA and a multifactorial disease such as AAA, one needs to consider the possibility that not all patients have a specific HLA type. Since multifactorial diseases occur, by definition, due to the existence of multiple factors, not all patients will have one specific factor, and not all patients with a specific factor develop the disease. Even in Takayasu disease (aortitis syndrome), which is a well-known autoimmune disease in the cardiovascular field, no significant relationship between this disease and class-II HLA has been recognized. However, its correlation with class-I HLA of B52 has been confirmed.
13±15
In our study, we could not detect significant association with HLA class-II in 49 AAA patients, but did detect a significant difference in class I molecules, HLA-A2 and HLA-B61. These data suggest that one of the genes involved in the pathogenesis of AAA is located within or near the class-I HLA region. Since AAA is a multifactorial disease, it is unlikely that the pathogenetic gene is located only in the HLA region. In future studies, it will be necessary to perform the genetic analysis outside of the HLA region, including those regulating endothelial and platelet functions.
In conclusion, there were significant increases in HLA-A2 and HLA-B61 frequency in AAA patients compared to controls. These results are the first to identify two class-I HLA genes as important genetic risk factors in the development of AAA in the Japanese population. We also showed in this study that both the HLA-B52 antigen and the HLA-DR B1 Ã 1502 allele were seen more frequently in the AAA patients with AIOD than those without. We believe that the risk of developing atherosclerotic diseases such as IHD in the long term is extremely high in AAA patients with these HLA genotypes.
